|
|
|
|
Julie M. Vose, MD
University of Nebraska Medical Center
|
| |
|
|
| |
| Since 1990, Dr. Julie Vose has been based at the University of Nebraska Medical Center in Omaha where she is currently Professor of Medicine. She has published 150 abstracts, 135 articles and authored 30 book chapters on various aspects of lymphoma care and research. Dr. Vose has been the principal investigator on numerous clinical trials evaluating new treatments using monoclonal antibodies, radioimmunotherapy and vaccine therapies. Last year, she took a sabbatical to research lymphoma vaccine therapy in Dr. Ronald Levy’s lab at Stanford University. Dr. Vose was on the FDA Biological Response Modifier Advisory Committee from 1993-1999, serving as chair of the committee for the last 2 years. She is Chair-elect for the American Bone Marrow Transplant Registry (ABMTR) and Chair of the Lymphoma Committee for AMBTR. |
|
| |
| Articles by Julie M. Vose, MD: |
|
|
| |
| Webcasts with Julie M. Vose, MD: |
|
|
